Literature DB >> 2143545

Intranuclear location of the adenovirus type 5 E1B 55-kilodalton protein.

J K Smiley1, M A Young, S J Flint.   

Abstract

The intracellular location of the adenovirus type 5 E1B 55-kilodalton (kDa) protein, particularly the question of whether it is associated with nuclear pore complexes, was examined. Fractionation of adenovirus type 5-infected HeLa cell nuclei by an established procedure (N. Dwyer and G. Blobel, J. Cell. Biol. 70:581-591, 1976) yielded one population of E1B 55-kDa protein molecules released by digestion of nuclei with RNase A and a second population recovered in the pore complex-lamina fraction. Free and E1B 55-kDa protein-bound forms of the E4 34-kDa protein (P. Sarnow, C. A. Sullivan, and A. J. Levine, Virology 120:387-394, 1982) were largely recovered in the pore complex-lamina fraction. Nevertheless, the association of E1B 55-kDa protein molecules with this nuclear envelope fraction did not depend on interaction of the E1B 55-kDa protein with the E4 34-kDa protein. Comparison of the immunofluorescence patterns observed with antibodies recognizing the E1B 55-kDa protein or cellular pore complex proteins and of the behavior of these viral and cellular proteins during in situ fractionation suggests that the E1B 55-kDa protein does not become intimately or stably associated with pore complexes in adenovirus-infected cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2143545      PMCID: PMC247928     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

1.  Inhibition of HeLa cell protein synthesis during adenovirus infection. Restriction of cellular messenger RNA sequences to the nucleus.

Authors:  G A Beltz; S J Flint
Journal:  J Mol Biol       Date:  1979-06-25       Impact factor: 5.469

2.  Adenoviral early region 4 is required for efficient viral DNA replication and for late gene expression.

Authors:  D H Weinberg; G Ketner
Journal:  J Virol       Date:  1986-03       Impact factor: 5.103

3.  Ultrastructural changes in KB cultures infected with adenovirus type 2.

Authors:  D M Phillips; H J Raskas
Journal:  Virology       Date:  1972-04       Impact factor: 3.616

4.  Studies on the interaction of the human c-myc protein with cell nuclei: p62c-myc as a member of a discrete subset of nuclear proteins.

Authors:  G I Evan; D C Hancock
Journal:  Cell       Date:  1985-11       Impact factor: 41.582

5.  Complex splicing patterns of RNAs from the early regions of adenovirus-2.

Authors:  L T Chow; T R Broker; J B Lewis
Journal:  J Mol Biol       Date:  1979-10-25       Impact factor: 5.469

6.  Nuclear envelope localization of an adenovirus tumor antigen maintains the integrity of cellular DNA.

Authors:  E White; S H Blose; B W Stillman
Journal:  Mol Cell Biol       Date:  1984-12       Impact factor: 4.272

7.  Adenovirus early region 4 encodes functions required for efficient DNA replication, late gene expression, and host cell shutoff.

Authors:  D N Halbert; J R Cutt; T Shenk
Journal:  J Virol       Date:  1985-10       Impact factor: 5.103

8.  Regulation of the appearance of cytoplasmic RNAs from region 1 of the adenovirus 2 genome.

Authors:  D J Spector; M McGrogan; H J Raskas
Journal:  J Mol Biol       Date:  1978-12-15       Impact factor: 5.469

9.  V-myc- and c-myc-encoded proteins are associated with the nuclear matrix.

Authors:  R N Eisenman; C Y Tachibana; H D Abrams; S R Hann
Journal:  Mol Cell Biol       Date:  1985-01       Impact factor: 4.272

10.  A modified procedure for the isolation of a pore complex-lamina fraction from rat liver nuclei.

Authors:  N Dwyer; G Blobel
Journal:  J Cell Biol       Date:  1976-09       Impact factor: 10.539

View more
  9 in total

1.  Effects of mutations in the adenoviral E1B 55-kilodalton protein coding sequence on viral late mRNA metabolism.

Authors:  Ramon A Gonzalez; S J Flint
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

2.  Localization of the adenovirus early region 1B 55-kilodalton protein during lytic infection: association with nuclear viral inclusions requires the early region 4 34-kilodalton protein.

Authors:  D A Ornelles; T Shenk
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

3.  The adenovirus E1B 55-kilodalton and E4 open reading frame 6 proteins limit phosphorylation of eIF2alpha during the late phase of infection.

Authors:  Megan E Spurgeon; David A Ornelles
Journal:  J Virol       Date:  2009-07-15       Impact factor: 5.103

4.  E1B 55-kilodalton-associated protein: a cellular protein with RNA-binding activity implicated in nucleocytoplasmic transport of adenovirus and cellular mRNAs.

Authors:  S Gabler; H Schütt; P Groitl; H Wolf; T Shenk; T Dobner
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

5.  Functional cooperation between human adenovirus type 5 early region 4, open reading frame 6 protein, and cellular homeobox protein HoxB7.

Authors:  Daniela Müller; Sabrina Schreiner; Melanie Schmid; Peter Groitl; Michael Winkler; Thomas Dobner
Journal:  J Virol       Date:  2012-05-02       Impact factor: 5.103

6.  Structural analysis of the adenovirus type 5 E1B 55-kilodalton-E4orf6 protein complex.

Authors:  S Rubenwolf; H Schütt; M Nevels; H Wolf; T Dobner
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

7.  Activation of RNA polymerase III transcription of human Alu repetitive elements by adenovirus type 5: requirement for the E1b 58-kilodalton protein and the products of E4 open reading frames 3 and 6.

Authors:  B Panning; J R Smiley
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

8.  mRNA export correlates with activation of transcription in human subgroup C adenovirus-infected cells.

Authors:  U C Yang; W Huang; S J Flint
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

9.  Adenoviral E1B-55kDa protein inhibits yeast mRNA export and perturbs nuclear structure.

Authors:  S Liang; M Hitomi; A M Tartakoff
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-01       Impact factor: 11.205

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.